Transdermal fluorescence detection of a dual fluorophore system for noninvasive point-of-care gastrointestinal permeability measurement

  • Dorshow R
  • Johnson J
  • Debreczeny M
  • et al.
11Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

© 2019 OSA - The Optical Society. All rights reserved. The intestinal mucosal barrier prevents macromolecules and pathogens from entering the circulatory stream. Tight junctions in this barrier are compromised in inflammatory bowel diseases, environmental enteropathy, and enteric dysfunction. Dual sugar absorption tests are a standard method for measuring gastrointestinal integrity, however, these are not clinically amenable. Herein, we report on a dual fluorophore system and fluorescence detection instrumentation for which gastrointestinal permeability is determined in a rat small bowel disease model from the longitudinal measured transdermal fluorescence of each fluorophore. This fluorophore technology enables a specimen-free, noninvasive, point-of-care gastrointestinal permeability measurement which should be translatable to human clinical studies.

Cite

CITATION STYLE

APA

Dorshow, R. B., Johnson, J. R., Debreczeny, M. P., Riley, I. R., Shieh, J.-J., Rogers, T. E., … Tarr, P. I. (2019). Transdermal fluorescence detection of a dual fluorophore system for noninvasive point-of-care gastrointestinal permeability measurement. Biomedical Optics Express, 10(10), 5103. https://doi.org/10.1364/boe.10.005103

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free